

| Drug common name | Tamibarotene |
| INN | tamibarotene |
| Description | Tamibarotene is a dicarboxylic acid monoamide resulting from the condensation of one of the carboxy groups of terephthalic acid with the amino group of 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine. It has a role as an antineoplastic agent and a retinoic acid receptor alpha/beta agonist. It is a member of tetralins, a retinoid and a dicarboxylic acid monoamide. It is functionally related to a 4-carbamoylbenzoic acid and a terephthalic acid. |
| Classification | Small molecule |
| Drug class | arotinoid derivatives |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 |
| PDB | — |
| CAS-ID | 94497-51-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL25202 |
| ChEBI ID | 32181 |
| PubChem CID | 108143 |
| DrugBank | DB04942 |
| UNII ID | 08V52GZ3H9 (ChemIDplus, GSRS) |

